2022, doi: 10.1002/cpt.2430
Less common but important other side effects include kidney disease and gallbladder issues, while severe risks may include pancreatitis and gallbladder disease
Common Questions About GLP-1 Medications Its smart to have questions about any new medication
Build every meal around a protein source
Furthermore, a recent extensive cohort study involving over 33,000 GLP-1 RA users diagnosed with diabetes over a 9-year period indicated no significant increase in pancreatic cancer risk associated with GLP-1 RA use, as evidenced by an HR of 0.50 compared to basal insulin [60]
Artificial Intelligence may allow for more accurate personalisation of therapy to predict the optimum cocktail of mono agonist therapies based on the genetics and metabolomics of an individual and may quicken the process of drug development [70, 71]